Literature DB >> 6103028

Metabolism of thymoxamine: identification of metabolites in rat.

C Feniou, B Neau, G Prat, C Cheze, F Fauran, J Roquebert.   

Abstract

Thymoxamine hydrochloride administered by mouth to rats at 25 or 100 mg kg-1 was excreted in the urine as the deacetyl and N-demethyl-deacetyl metabolites. These were completely sulpho- and glucuronoconjugated at 25 mg kg-1 but only partially so at the higher dose. Thymoxamine deacetylation in vitro is catalysed by plasma and hepatic cytosol esterases and the deacetyl metabolite undergoes N-demethylation catalysed by the cytochrome P 450 hepatic microsome mixed function monooxygenase system. Because of the rapidity of the deacetylation it is concluded that thymoxamine is a prodrug leading in vivo to the active deacetyl thymoxamine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103028     DOI: 10.1111/j.2042-7158.1980.tb12862.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Metabolism of thymoxamine. I. Studies with 14C-thymoxamine in rats.

Authors:  K O Vollmer; B Liedtke; A Poisson; A von Hodenberg; W Steinbrecher
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jan-Mar       Impact factor: 2.441

2.  Pharmacokinetics of thymoxamine in rabbits after ophthalmic and intravenous administration.

Authors:  I Aldana; E González-Peñas; D Fos; L Bruseghini; A Esteras; N Ceppi Monti; V Gianesello
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

3.  Pharmacokinetics of a prodrug thymoxamine: dose-dependence of the metabolite ratio in healthy subjects.

Authors:  C Marquer; J H Trouvin; J Y Lacolle; C Dupont; C Jacquot
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.